Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 1
2008 4
2009 3
2010 6
2011 2
2012 10
2013 11
2014 11
2015 8
2016 10
2017 14
2018 12
2019 16
2020 25
2021 22
2022 18
2023 28
2024 18
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Results by year

Filters applied: . Clear all
Page 1
Nerandomilast in Patients with Progressive Pulmonary Fibrosis.
Maher TM, Assassi S, Azuma A, Cottin V, Hoffmann-Vold AM, Kreuter M, Oldham JM, Richeldi L, Valenzuela C, Wijsenbeek MS, Clerisme-Beaty E, Coeck C, Gu H, Ritter I, Schlosser A, Stowasser S, Voss F, Weimann G, Zoz DF, Martinez FJ; FIBRONEER-ILD Trial Investigators. Maher TM, et al. N Engl J Med. 2025 Jun 12;392(22):2203-2214. doi: 10.1056/NEJMoa2503643. Epub 2025 May 19. N Engl J Med. 2025. PMID: 40388329 Clinical Trial.
Immune checkpoint inhibitor-induced musculoskeletal manifestations.
Angelopoulou F, Bogdanos D, Dimitroulas T, Sakkas L, Daoussis D. Angelopoulou F, et al. Among authors: dimitroulas t. Rheumatol Int. 2021 Jan;41(1):33-42. doi: 10.1007/s00296-020-04665-7. Epub 2020 Aug 2. Rheumatol Int. 2021. PMID: 32743706 Review.
Primary Sjögren's Syndrome and Cardiovascular Disease.
Melissaropoulos K, Bogdanos D, Dimitroulas T, Sakkas LI, Kitas GD, Daoussis D. Melissaropoulos K, et al. Among authors: dimitroulas t. Curr Vasc Pharmacol. 2020;18(5):447-454. doi: 10.2174/1570161118666200129125320. Curr Vasc Pharmacol. 2020. PMID: 31995009 Review.
Cardiovascular Disease in the Systemic Vasculitides.
Soulaidopoulos S, Madenidou AV, Daoussis D, Melissaropoulos K, Mavrogeni S, Kitas G, Dimitroulas T. Soulaidopoulos S, et al. Among authors: dimitroulas t. Curr Vasc Pharmacol. 2020;18(5):463-472. doi: 10.2174/1570161118666200130093432. Curr Vasc Pharmacol. 2020. PMID: 32000652 Review.
Attainment of EULAR/ERA-EDTA targets of therapy with current immunosuppressive regimens and adjustments in treatment: a multicentre, real-life observational study.
Pappa M, Kosmetatou M, Pieta A, Nikoloudaki M, Liapis NM, Tsalapaki C, Chalkia A, Argyriou E, Dimitroulas T, Cheila M, Demirtzoglou G, Papagoras C, Goules A, Katsiari C, Vassilopoulos D, Sidiropoulos P, Boki KA, Sfikakis PP, Liapis G, Gakiopoulou H, Voulgari PV, Boumpas DT, Bertsias G, Tektonidou MG, Fanouriakis A. Pappa M, et al. Among authors: dimitroulas t. RMD Open. 2024 Sep 18;10(3):e004437. doi: 10.1136/rmdopen-2024-004437. RMD Open. 2024. PMID: 39299738 Free PMC article.
210 results